Literature DB >> 16510047

Imaging of atherosclerosis using magnetic resonance: state of the art and future directions.

Milind Y Desai1, João A C Lima.   

Abstract

Atherosclerosis is the leading cause of morbidity and mortality in industrialized societies, and its incidence is projected to increase in the future. Because the atherosclerotic process begins in the vessel wall, the focus of cardiovascular imaging is shifting from the arterial lumen to imaging of the vessel wall, with the goal of detecting preclinical atherosclerosis. MRI, because of its high resolution, three-dimensional capabilities, noninvasive nature, and capacity for soft tissue characterization, is emerging as an important modality to assess the atherosclerotic plaque burden in the arterial wall and can monitor atherosclerosis in different arterial beds, including the carotid arteries, aorta, and more recently, the coronary arteries. Furthermore, it has also been successfully utilized to monitor plaque regression following therapeutic interventions. Finally, the emergence of high-resolution MRI and development of sophisticated contrast agents offers tremendous promise for in vivo molecular imaging of the atherosclerotic plaque.

Entities:  

Mesh:

Year:  2006        PMID: 16510047     DOI: 10.1007/s11883-006-0050-8

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  84 in total

1.  Submillimeter three-dimensional coronary MR angiography with real-time navigator correction: comparison of navigator locations.

Authors:  M Stuber; R M Botnar; P G Danias; K V Kissinger; W J Manning
Journal:  Radiology       Date:  1999-08       Impact factor: 11.105

2.  3D coronary vessel wall imaging utilizing a local inversion technique with spiral image acquisition.

Authors:  R M Botnar; W Y Kim; P Börnert; M Stuber; E Spuentrup; W J Manning
Journal:  Magn Reson Med       Date:  2001-11       Impact factor: 4.668

3.  Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy.

Authors:  João A C Lima; Milind Y Desai; Henning Steen; William P Warren; Sandeep Gautam; Shenghan Lai
Journal:  Circulation       Date:  2004-10-11       Impact factor: 29.690

4.  Fast selective black blood MR imaging.

Authors:  R R Edelman; D Chien; D Kim
Journal:  Radiology       Date:  1991-12       Impact factor: 11.105

5.  In vitro and in situ magnetic resonance imaging signal features of atherosclerotic plaque-associated lipids.

Authors:  C Yuan; C Petty; K D O'Brien; T S Hatsukami; J F Eary; B G Brown
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-08       Impact factor: 8.311

6.  Surrogate endpoints in clinical trials: cardiovascular diseases.

Authors:  J Wittes; E Lakatos; J Probstfield
Journal:  Stat Med       Date:  1989-04       Impact factor: 2.373

7.  A monitoring, feedback, and triggering system for reproducible breath-hold MR imaging.

Authors:  Y L Liu; S J Riederer; P J Rossman; R C Grimm; J P Debbins; R L Ehman
Journal:  Magn Reson Med       Date:  1993-10       Impact factor: 4.668

8.  Carotid artery atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging initial results.

Authors:  Bruce A Wasserman; William I Smith; Hugh H Trout; Richard O Cannon; Robert S Balaban; Andrew E Arai
Journal:  Radiology       Date:  2002-05       Impact factor: 11.105

9.  Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization?

Authors:  O J de Boer; A C van der Wal; P Teeling; A E Becker
Journal:  Cardiovasc Res       Date:  1999-02       Impact factor: 10.787

10.  Visualization of fibrous cap thickness and rupture in human atherosclerotic carotid plaque in vivo with high-resolution magnetic resonance imaging.

Authors:  T S Hatsukami; R Ross; N L Polissar; C Yuan
Journal:  Circulation       Date:  2000-08-29       Impact factor: 29.690

View more
  5 in total

1.  Usefulness of cardiovascular magnetic resonance imaging of the superficial femoral artery for screening patients with diabetes mellitus for atherosclerosis.

Authors:  Jamieson M Bourque; Brian J Schietinger; Jamie L Kennedy; Emily A Pearce; John M Christopher; Angela M Taylor; Coleen A McNamara; Christopher M Kramer
Journal:  Am J Cardiol       Date:  2012-03-27       Impact factor: 2.778

2.  Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes.

Authors:  Karen C Briley-Saebo; Young Seok Cho; Peter X Shaw; Sung Kee Ryu; Venkatesh Mani; Stephen Dickson; Ehsan Izadmehr; Simone Green; Zahi A Fayad; Sotirios Tsimikas
Journal:  J Am Coll Cardiol       Date:  2010-11-23       Impact factor: 24.094

3.  Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes.

Authors:  Karen C Briley-Saebo; Peter X Shaw; Willem J M Mulder; Seung-Hyuk Choi; Esad Vucic; Juan Gilberto S Aguinaldo; Joseph L Witztum; Valentin Fuster; Sotirios Tsimikas; Zahi A Fayad
Journal:  Circulation       Date:  2008-06-09       Impact factor: 29.690

4.  In vivo imaging of macrophages during the early-stages of abdominal aortic aneurysm using high resolution MRI in ApoE mice.

Authors:  Yuyu Yao; Yuanyuan Wang; Yi Zhang; Yefei Li; Zulong Sheng; Song Wen; Genshan Ma; Naifeng Liu; Fang Fang; Gao-Jun Teng
Journal:  PLoS One       Date:  2012-03-20       Impact factor: 3.240

5.  Ex-vivo Assessment of Coronary Artery Atherosclerosis by Magnetic Resonance Imaging: Correlation with Histopathology.

Authors:  Everli P S Gonçalves Gomes; Carlos Eduardo Rochitte; Clerio F Azevedo; Pedro A Lemos; Paulo Sampaio Gutierrez; Luiz Antonio M César
Journal:  Open Cardiovasc Med J       Date:  2014-04-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.